Exhibit 99.1
FOR: | NUTRACEUTICAL INTERNATIONAL CORPORATION |
| |
CONTACT: | Cory J. McQueen |
| Vice President and |
| Chief Financial Officer |
| (435) 655-6106 |
NUTRACEUTICAL REPORTS FISCAL 2008 Q1 RESULTS
PARK CITY, Utah, Jan 31/PRNewswire-First Call/—Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2008 first quarter ended December 31, 2007. Net sales for the fiscal 2008 first quarter were $41.1 million compared to $35.8 million for the same quarter of fiscal 2007. For the first quarter of fiscal 2008, net income was $3.2 million, or $0.28 diluted earnings per share, compared to net income of $3.4 million, or $0.30 diluted earnings per share, for the same quarter of fiscal 2007.
Bill Gay, chairman and chief executive officer, commented, “The growth in net sales of approximately 15% for the first quarter of fiscal 2008 compared to the same quarter of fiscal 2007 reflects the positive contributions of the six acquisitions completed during fiscal 2007. We remain focused on expanding our branded product sales through innovative marketing and sales programs that build long-term loyalty with our health and natural food store customers. Improved profitability and EBITDA from our acquisitions can normally be achieved within one to two years. Managing controllable expenses and gaining consolidation synergies from the fiscal 2007 acquired businesses will remain a dominant goal for the next few quarters. In spite of the current US economic slowdown, cost pressures and increasing competitive conditions, we remain confident in our business as we strive to serve our customers and take advantage of synergistic opportunities in the Healthy Foods Channel. We appreciate everyone that has helped us build a strong and successful business in the nutritional industry.”
ABOUT NUTRACEUTICAL
We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Our core business strategy is to acquire, integrate and operate, from beginning to end, the manufacturing, marketing and distribution of branded nutritional supplement businesses in the natural products industry. We believe that the consolidation and integration of these acquired businesses provides ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.
We sell branded nutritional supplements and other natural products under the trademarks Solaray®, VegLife®, KAL®, Nature’s Life®, Sunny Green®, Action Labs®, Natural Balance®, NaturalMax®, bioAllers®, Herbs for KidsTM, Natra-Bio®, NaturalCare®, Zand®, Life-flo®, Larénim®, Living Flower
Essences®, Pioneer®, Thompson®, Natural Sport®, Supplement Training Systems®, Premier One®, Montana Big Sky™, ActiPet®, FunFresh Foods™, Dowd & Rogers™, CompliMed®, AllVia™, Healthway®, Body Gold®, Sayge Biosciences™, Monarch Nutritional Laboratories™ and Great Basin Botanicals™. Under the name Woodland Publishing™, we publish, print and market a line of books and booklets to, among others, book distributors, national retail bookstores and health and natural food stores. We also distribute branded products of certain third parties.
We own neighborhood natural food markets, which operate under the trade names The Real Food Company ™, Thom’s Natural Foods™ and Cornucopia Community Market™. We also own health food stores, which operate under the trade names Fresh Vitamins™, Granola’s™ and Pilgrim’s Natureway™.
We manufacture and/or distribute one of the broadest branded product lines in the industry with over 3,900 SKUs, including over 700 SKUs sold internationally. We believe that as a result of our emphasis on innovation, quality, loyalty, education and customer service, our brands are widely recognized in health and natural food stores and among their customers.
This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. We undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Press Release. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to, government regulations, product liability claims and litigation, insurance coverage issues, a decrease in or slowing of the growth rate of the vitamin, mineral and supplement market, the success of the healthy foods channel, consumer perception of safety and quality of our products and similar products, competition, intellectual property rights of other parties, the loss of key personnel, disruptions from acquisitions, issues with obtaining raw materials of adequate quality or quantity, problems with information management systems, manufacturing efficiencies and operations, litigation generally, the volatility of the stock market generally and of our stock specifically, a general lack of adequate industry analyst coverage, and other factors indicated from time to time in our SEC reports, copies of which are available upon request from our investor relations group or which may be obtained at the SEC’s website (www.sec.gov).
© 2008 Nutraceutical Corporation. All rights reserved.
# # #
NUTRACEUTICAL INTERNATIONAL CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited; dollars in thousands)
| | December 31, | | September 30, | |
| | 2007 | | 2007 | |
Assets | | | | | |
Current assets, net | | $ | 49,904 | | $ | 51,534 | |
Property, plant and equipment, net | | 42,367 | | 39,506 | |
Goodwill | | 39,066 | | 38,978 | |
Other non-current assets, net | | 15,898 | | 16,384 | |
| | $ | 147,235 | | $ | 146,402 | |
| | | | | |
Liabilities and Stockholders’ Equity | | | | | |
Current liabilities | | $ | 17,725 | | $ | 20,275 | |
Long-term liabilities | | 21,227 | | 20,208 | |
Stockholders’ equity | | 108,283 | | 105,919 | |
| | $ | 147,235 | | $ | 146,402 | |
NUTRACEUTICAL INTERNATIONAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited; dollars in thousands, except per share data)
| | Three months ended December 31, | |
| | 2007 | | 2006 | |
Net sales | | $ | 41,086 | | $ | 35,848 | |
Cost of sales | | 18,773 | | 16,324 | |
Gross profit | | 22,313 | | 19,524 | |
Operating expenses | | | | | |
Selling, general and administrative | | 16,628 | | 13,922 | |
Amortization of intangible assets | | 167 | | 46 | |
Income from operations | | 5,518 | | 5,556 | |
Interest and other (income)/expense, net | | 380 | | 144 | |
Income before provision for income taxes | | 5,138 | | 5,412 | |
Provision for income taxes | | 1,927 | | 2,057 | |
| | | | | |
Net income | | $ | 3,211 | | $ | 3,355 | |
| | | | | |
Net income per common share | | | | | |
Basic | | $ | 0.29 | | $ | 0.30 | |
Diluted | | 0.28 | | 0.30 | |
| | | | | |
Weighted average common shares outstanding | | | | | |
Basic | | 11,123,792 | | 11,015,967 | |
Diluted | | 11,270,089 | | 11,212,285 | |
NUTRACEUTICAL INTERNATIONAL CORPORATION
EBITDA SCHEDULE
(unaudited; dollars in thousands)
| | Three months ended December 31, | |
| | 2007 | | 2006 | |
Net income | | $ | 3,211 | | $ | 3,355 | |
Provision for income taxes | | 1,927 | | 2,057 | |
Interest and other (income)/expense, net (1) | | 380 | | 144 | |
Depreciation and amortization | | 1,312 | | 1,101 | |
| | | | | |
EBITDA | | $ | 6,830 | | $ | 6,657 | |
(1) Includes amortization of deferred financing fees and losses associated with fixed asset disposals.
